Navigation Links
Fortune Names Mesa Laboratories as one of America's Fastest Growing Small Public Companies
Date:7/14/2009

LAKEWOOD, Colo., July 14 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) announced today that it has been named to the Fortune Small Business Magazine's (FSB) annual list of the 100 fastest-growing, publicly held small companies in the U.S. Every year the editors of FSB analyze public companies with annual revenues of less than $200 million and rank them based on growth in revenues and stock performance over the past three years. This is the second year that Mesa Labs was included in the FSB list, moving up to position 18 out of 100 companies, from number 62 last year. For more information about the FSB 100 list visit http://money.cnn.com/magazines/fsb/fsb100/2009/.

"Being named to the FSB 100 list for the second year in a row is a great honor," said John J. Sullivan, President and CEO. "We all know that the economy is especially challenging today and the fact that we were able to report growth of both revenue and net income for our recently completed fiscal year is a reflection of the extra effort that everyone at Mesa has contributed. As we navigate through these tough economic times, we continue our focus on strategic growth initiatives revolving around improving our channels of distribution, accelerating our new product introductions and seeking out the acquisition of synergistic product lines and companies. We look forward to continuing our growth strategy and staying on the FSB 100 list in the years ahead."

Mesa Laboratories, Inc. is a public Colorado corporation that develops, manufactures, and markets instruments and disposable products utilized in connection with industrial applications and healthcare. For industrial applications, which include pharmaceutical, food, and medical devices, the Company presently markets the DATATRACE(R) data logging systems and RAVEN Biological Indicators. For healthcare applications, the Company markets Dialysate Meters, which are used for quality control in kidney dialysis clinics and RAVEN Biological Indicators, which are used by hospitals and dental offices to assure sterility. The Company is continually performing research and development to expand the application of its technology. For more information visit the Company's web site at www.mesalabs.com.

This news release contains forward-looking statements which involve risks and uncertainties. The Company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2009 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fortune Recognizes Female Health Company as One of Americas Fastest-Growing Small Companies
2. Local Company Offers Micro-Businesses Fortune 500-Style Administrative Services in a Competitive Economy
3. DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
4. Play the Winning Hand - Watching Your Fortunes Grow in Skin Care
5. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
6. Medco Tops Fortunes Lists of Worlds Most Admired Companies
7. Quest Diagnostics Again Named to FORTUNE Magazines Worlds Most Admired Companies List
8. FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality
9. BD Ranks 23rd on EPAs Fortune 500 List of Green Power Purchasers
10. Whole Foods Market(R) Makes FORTUNEs 100 Best Companies to Work For List for 12th Consecutive Year
11. Novo Nordisk Makes its Debut in FORTUNEs 100 Best Companies to Work For
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: